as well as because TAC1 is related to the functional pathway of the MYOC gene whose mutations are linked to glaucoma. Moreover, given that this girl is clinically reminiscent of several phenotypes related to diverse deletions within 7q21q32, our results and observations offer a general overview of the gene content of deletions/phenotypes overlapping 7q21.3q31.1 and confirm that loci distal to DLX genes including the CUX1 gene and potential regulatory elements downstream from DLX5 are unrelated to ectrodactyly.
Diverse deletions within the 7q21q32 segment have often been associated with ectrodactyly and multiple clinical features, such as intellectual disability/developmental delay, ear/hearing anomalies, low birth weight, feeding problems, unusual cry, microcephaly, micrognathia, cardiac and palate defects, recurrent infections, abnormal palmar creases, and eye abnormalities [Young et al., 1984; Rivera et al., 1991; Scherer et al., 1994; Montgomery et al., 2000; Bernardini et al., 2008; Cheong et al., 2008; van Silfhout et al., 2009] . This phenotypic consistency along with the apparent overlapping of the deleted regions may indeed represent a recognizable deletion syndrome [Fagan et al., 1989] . Here, we report on a girl with a 7q21.3q31.1 deletion and congenital severe glaucoma (but not ectrodactyly) in order to refine the mapping of and provide further insights on ocular phenotypes related to intermediate (q21 → 31/32) deletions.
Patient Description
The patient, a 1-year-old girl, is the second child of healthy non-consanguineous parents. The family history was unremarkable. Foetal growth retardation, short femur and calcification of the placenta were detected in the third trimester; she was born by caesarean section at 35 weeks of gestation due to increased foetal risk. Birth weight was 2,300 g (<3rd percentile), length was 43 cm (<3rd percentile) and the only Apgar score referred to was 8. Congenital glaucoma was detected and treated by trabeculectomy in 2 different interventions. The patient still remains with elevated intraocular pressure. Brain magnetic resonance imaging revealed increased subarachnoid space, altered myelinisation process and bilateral optic nerve oedema. At the age of 7 months, her weight was 4,300 g (between 10 and 25th percentile) and length 57.3 cm (<3rd percentile). She presented with big eyes, blue sclerae, wide fontanelles, prominent eyebrows, low-set ears with overfolded helix, upslanting palpebral fissures, apparent telecanthus, bulbous nasal tip, hypoplastic nasal alae, short columella, apparently increased distance between nasal base and midline upper lip vermilion border, thin lips, marked Cupid's bow, cleft soft palate, micrognathia, bilateral single palmar crease, and bilateral fifth finger clinodactyly ( fig. 1 A) . In addition, she had foramen ovale, patent ductus arteriosus and tricuspid regurgitation. At 12 months, she is still unable to control her head. Her reaction to auditory stimuli is poor, but she follows light stimuli. She has not developed any teeth, has a weak cry, and her weight, length and OFC were 5,500 g (<3rd percentile), 67.5 cm (<3rd percentile) and 42 cm (<3 percentile), respectively. An ophthalmological evaluation described bilateral primary congenital glaucoma characterised by buphthalmos, elevated intraocular pressure, thin and bluish anterior sclera, and corneal oedema with corneal opacification. Uveal structures, including iris, were apparently normal, although iris implantation could not be defined. Currently, she is recovering from episodes of recurrent respiratory infection.
Material and Methods

Chromosomal Analysis
Initial cytogenetic analyses of the patient and her parents were made on GTG-banded metaphase chromosomes obtained from 72 h lymphocyte cultures. Further blood samples from the patient and her parents, taken under informed consent, were used to perform the molecular studies.
Array CGH
Initially, genomic DNA from the patient and her parents was obtained from 3 ml of peripheral blood with the Qiagen Gentra ® Puregene Blood core Kit. Medium-density microarray analysis was performed using the Agilent SurePrint G3 Hmn CGH+SNP 4x180K Microarray Kit (contains ∼ 120,000 CGH probes and 60,000 SNP probes with median spacing of 25 kb). Briefly, genomic DNA ( ∼ 1 mg) from the patient and her parents and from sex-matched controls was digested by Alu I and Rsa I restriction enzymes (Promega, Madison, Wisc., USA) for 2 h at 37 ° C. The digested products were labelled with Cy3-dUTP and Cy5-dUTP fluorochromes using the Sure tag DNA Labelling Kit (Agilent Technologies). The labelled products were purified, hybridised and washed according to Agilent protocols. Each slide was scanned on a Nimblegen MS 200 scanner (Roche), and the resulting images were converted by image conversion software and imaged by Feature Extraction software (Agilent technologies). Results were analysed using default analysis method -CGH+SNP v2 with the ADM-2 aberration algorithm by Agilent CytoGenomics software v.2.5.
Results
The patient's G-banded karyotype was 46,XX,del(7) (q22q22)dn; parental karyotypes were normal. The corresponding microarray assay disclosed a deleted 12.5-Mb region (genomic position 96,742,140-109,246,085), embracing 500 markers and 229 genes (including miRNAs and hypothetical proteins) with ACN9 being the more proximal and C7orf66 the more distal (GRCh37/hg19); thus, there was a partial monosomy for 7q21.3q31.1 ( fig. 1 B) . This deletion overlaps with the ectrodactyly original critical region [Scherer et al., 1994 ], but did not include DLX5 and DLX6 genes, the major candidates for such clinical feature. No other remarkable genomic change was observed. Microarray results from the parents were normal. The patient's final karyotype was 46,XX.arr 7q21.3q31.1 (96, 742, 246 ,085)×1 dn.
Discussion
In this study, the fourth patient described so far with congenital glaucoma related to a constitutional de novo deletion involving or overlapping the 7q21.3q31.1 region After this review, a very similar deletion to our case was described in a 24-week-old foetus who presented a cleft lip and palate, hypertelorism, a broad nasal bridge, micrognathia, low-set ears, a micropenis and cryptorchidism [Chen et al., 2013] . In this table, features presented in >30% of cases are: ID/ DD (~18/18), eye anomalies (12/18), low birth weight (10/18), ear malformations (10/18), heart defects (9/18), large mouth (9/18), feeding problems (9/18), low-set ears (8/18), growth retardation/short stature (8/18), hypotonia (6/18), microcephaly (6/18), micrognathia (6/18), abnormal palmar creases (6/18), and genital anomalies (6/18). The feature 'weak cry' or 'unusual cry' was not included in the present table, but it was present in ~5 patients including the present one. ( fig. 1 C; table 1 ) is presented. Our results suggest that codeletion of at least 3 eye-related loci (TAC1 , CYP3A43 and HBP1) mapped in this region could account for glaucoma and other ocular abnormalities.
Glaucoma, a clinically and genetically heterogeneous condition, is characterised by loss of retinal ganglion cells and atrophy of the optic nerve [Izzotti et al., 2011; Mookherjee et al., 2012] . The major clinical criterion of increased intraocular pressure usually results from resistance of the trabecular meshwork to the aqueous humour . The trabecular meshwork is located around the base of the cornea and plays an important role in regulating the aqueous humour outflow [Izzotti et al., 2011] . Alterations in trabecular meshwork have frequently been found in patients with congenital glaucoma. Congenital glaucoma, cloudy cornea, primary open-angle glaucoma, and juvenile open-angle glaucoma are some of the subtypes of glaucoma and have been related to diverse loci such as GLC1A or MYOC (1q24.3), CYP1B1 (2p22.2), and CAV1 / CAV2 (7q31.2) [Stoilov et al., 1997; Alward et al., 1998; Thorleifsson et al., 2010; Kennedy et al., 2012; Mookherjee et al., 2012] .
The CYP1B1 gene has been linked to primary congenital glaucoma with cytochrome-P450-dependent metabolites regulating corneal transparency and aqueous humour secretion (OMIM 231300). Furthermore, CYP1B1 was downregulated and CYP26B1 upregulated in human trabecular meshwork cells with a mutated MYOC gene . These facts suggest that other genes of the cytochrome P450s family could be related as well. Actually, a small cluster of cytochrome P450 genes at 7q22.1 (CYP3A4, CYP3A5 , CYP3A7 , and CYP3A43) was deleted in our patient; in fact, most of the deletions in 7q associated with glaucoma or other ocular abnormalities such as cloudy corneas, macrocornea or abnormal pupils involved q22 and likely, CYP s genes [Young et al., 1984; Montgomery et al., 2000] . Remarkably, CY-P3A43 was found differentially expressed in human cornea epithelium tissue [Turner et al., 2007] . In general, members of the subfamily 3A were found expressed in human iris, ciliary body and cornea [Zhang et al., 2008; Volotinen et al., 2011] . Another candidate gene for glaucoma appears to be TAC1 , also deleted in our patient, which has recently been suggested as a possible physiological biomarker for glaucomatous injury. The TAC1 gene was related to the functional pathway of the MYOC gene, which is a glycoprotein induced by stress conditions in trabecular meshwork. Actually, TAC1 expression was also strongly altered in MYOC mutant cells [Kennedy et al., 2012] . The TAC1 gene (7q21.3) encodes for precursors of hormones that act as neurotransmitters (UCSC genome browser) and has been identified as a mechanosensible gene in the human trabecular meshwork .
Another gene also deleted in this patient, namely HBP1 , is a transcriptional repressor that participates in the WNT pathway and is expressed in retina, cornea and ciliary bodies (EMBL-EBI and GeneCards databases). The WNT pathway has been associated to intraocular pressure regulation . Coincidentally, the HBP1 (high mobility group box transcription factor) gene is alike to HMGB1 (high-mobility group box 1 protein) that is known to be an endogenous molecule for signalling of retinal damage and inflammatory stress .
Although most cases with ocular defects and deletions within or overlapping the 7q21.3q31.1 region were reported before methods for a precise genetic delineation were available, it seems feasible that in at least 9 patients with glaucoma or other ocular abnormalities [Ayraud et al., 1976; Dennis et al., 1977; Franceschini et al., 1978; Serup, 1980; Young et al., 1984; Fagan et al., 1989; Tajara et al., 1989; Morey et al., 1990; Montgomery et al., 2000] , the respective deletions involved all the above-mentioned genes ( fig. 1 C) . A further detailed review in DECIPHER and ISCA showed that among ∼ 39 deletions of or overlapping the 7q21.3q31.1 region ( fig. 1 D) , none exhibited the breakpoints here defined or included all 3 genes here proposed. The most similar 7q deletion, molecularly defined (98, 423, 872, 943) , was very recently reported by Chen et al. [2013] , but it did not include TAC1 and neither ocular abnormalities were reported in the foetus. The non-deleted status of CAV1 / CAV2 loci in our patient is consistent with the lack of ocular abnormalities seen in 8 patients with CAV1 / CAV2 hemizygosity. Accordingly, it is tempting to speculate that the proneness to ocular defects inherent to 7q intermediate deletions could largely be caused by co-deletion of the critical genes proposed here. It is worth noting, however, that practically all of the imbalances were related to intellectual disability/developmental delay and multiple sub-regions overlapped ( fig. 1 C,  D; table 1 ) .
In spite of the wide phenotypical spectrum of 7q21q32 deletions, several recurrent clinical features have been observed ( table 1 ) . According to the information gathered in table 1 , at least 14 features had a frequency >30% in those patients ( table 1 ) . For instance, the child in this study described exhibited at least 11 of these features, including intellectual disability/developmental delay, growth retardation, and craniofacial, heart and eye defects. Addition-ally, breakpoints analysis revealed that the proximal breakpoint of the present deletion lies just 88 kb downstream of the DLX5 gene. Because haploinsufficiency for DLX5 and DLX6 genes appears to be responsible for ectrodactyly [Scherer et al., 1994; van Silfhout et al., 2009] , our observation indirectly confirms the exclusion of the CUX1 gene (as suggested by Bernardini et al. [2008] ) and potential regulatory elements (as suggested by Tzschach et al. [2007] ) downstream of DLX5 and ACN9 (between RP11-800O14 and D7S618) in determining such a limb defect.
Overall, our findings confirm that 7q21.3q31.1 is a gene-rich region crucial for brain, heart, growth, and eye physiology/development ( table 2 ), offer a general overview of the gene content of deletions/phenotypes overlapping 7q21.3q31.1, and further strengthen that loci distal to DLX genes are unrelated to ectrodactyly.
